--Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its partnership with Enamine, a world-renowned provider of novel molecules ...

Recursion Pharmaceuticals is a leader in TechBio with potential to bring in $200M in near-term milestones and $20B in future revenue, according to Needham.

Salt Lake City-based biotech company Recursion Pharmaceuticals released a dataset of genetically altered cell images on May 6 that can be downloaded at no cost and aims to improve the use of ...